カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/08/26 | 1,088 | 1,091 | 1,083 | 1,084 | -10 | -0.9% | 7,200 |
| 2022/08/25 | 1,094 | 1,098 | 1,079 | 1,094 | +1 | +0.1% | 10,800 |
| 2022/08/24 | 1,087 | 1,095 | 1,084 | 1,093 | +9 | +0.8% | 4,800 |
| 2022/08/23 | 1,109 | 1,109 | 1,084 | 1,084 | -26 | -2.3% | 18,500 |
| 2022/08/22 | 1,105 | 1,110 | 1,091 | 1,110 | +3 | +0.3% | 13,600 |
| 2022/08/19 | 1,131 | 1,132 | 1,105 | 1,107 | -24 | -2.1% | 30,800 |
| 2022/08/18 | 1,171 | 1,175 | 1,118 | 1,131 | -15 | -1.3% | 55,400 |
| 2022/08/17 | 1,156 | 1,169 | 1,127 | 1,146 | -10 | -0.9% | 34,500 |
| 2022/08/16 | 1,135 | 1,168 | 1,135 | 1,156 | +27 | +2.4% | 47,400 |
| 2022/08/15 | 1,100 | 1,132 | 1,099 | 1,129 | +36 | +3.3% | 60,400 |
| 2022/08/12 | 1,077 | 1,094 | 1,060 | 1,093 | +29 | +2.7% | 28,100 |
| 2022/08/10 | 1,103 | 1,115 | 1,054 | 1,064 | -39 | -3.5% | 75,600 |
| 2022/08/09 | 1,060 | 1,245 | 1,060 | 1,103 | +78 | +7.6% | 661,500 |
| 2022/08/08 | 1,030 | 1,030 | 1,015 | 1,025 | -3 | -0.3% | 15,300 |
| 2022/08/05 | 1,030 | 1,045 | 1,023 | 1,028 | -2 | -0.2% | 19,600 |
| 2022/08/04 | 1,059 | 1,059 | 1,030 | 1,030 | -20 | -1.9% | 17,100 |
| 2022/08/03 | 1,050 | 1,067 | 1,049 | 1,050 | -2 | -0.2% | 19,600 |
| 2022/08/02 | 1,066 | 1,079 | 1,048 | 1,052 | -14 | -1.3% | 32,400 |
| 2022/08/01 | 1,138 | 1,143 | 1,062 | 1,066 | -84 | -7.3% | 86,800 |
| 2022/07/29 | 1,132 | 1,185 | 1,132 | 1,150 | +22 | +2% | 75,900 |
| 2022/07/28 | 1,135 | 1,140 | 1,110 | 1,128 | +17 | +1.5% | 35,300 |
| 2022/07/27 | 1,149 | 1,149 | 1,101 | 1,111 | -40 | -3.5% | 40,600 |
| 2022/07/26 | 1,170 | 1,171 | 1,141 | 1,151 | -19 | -1.6% | 42,800 |
| 2022/07/25 | 1,231 | 1,239 | 1,136 | 1,170 | -100 | -7.9% | 263,800 |
| 2022/07/22 | 1,170 | 1,300 | 1,134 | 1,270 | +128 | +11.2% | 266,600 |
| 2022/07/21 | 1,144 | 1,170 | 1,126 | 1,142 | +16 | +1.4% | 38,700 |
| 2022/07/20 | 1,152 | 1,154 | 1,087 | 1,126 | -50 | -4.3% | 58,100 |
| 2022/07/19 | 1,179 | 1,215 | 1,119 | 1,176 | -20 | -1.7% | 89,700 |
| 2022/07/15 | 1,120 | 1,307 | 1,081 | 1,196 | +91 | +8.2% | 388,600 |
| 2022/07/14 | 1,064 | 1,108 | 1,064 | 1,105 | +43 | +4% | 27,400 |
| 2022/07/13 | 1,051 | 1,062 | 1,045 | 1,062 | +9 | +0.9% | 5,100 |
| 2022/07/12 | 1,045 | 1,057 | 1,042 | 1,053 | -5 | -0.5% | 4,800 |
| 2022/07/11 | 1,061 | 1,061 | 1,043 | 1,058 | +3 | +0.3% | 8,800 |
| 2022/07/08 | 1,040 | 1,066 | 1,031 | 1,055 | +26 | +2.5% | 35,500 |
| 2022/07/07 | 1,024 | 1,029 | 1,017 | 1,029 | +7 | +0.7% | 9,300 |
| 2022/07/06 | 1,020 | 1,024 | 1,011 | 1,022 | +2 | +0.2% | 7,100 |
| 2022/07/05 | 1,011 | 1,020 | 1,000 | 1,020 | +24 | +2.4% | 11,600 |
| 2022/07/04 | 998 | 1,013 | 992 | 996 | +3 | +0.3% | 6,900 |
| 2022/07/01 | 1,005 | 1,018 | 987 | 993 | -12 | -1.2% | 4,900 |
| 2022/06/30 | 1,016 | 1,019 | 1,003 | 1,005 | -9 | -0.9% | 4,800 |
| 2022/06/29 | 1,003 | 1,019 | 1,003 | 1,014 | -2 | -0.2% | 5,000 |
| 2022/06/28 | 1,006 | 1,022 | 999 | 1,016 | +10 | +1% | 11,000 |
| 2022/06/27 | 984 | 1,006 | 984 | 1,006 | +24 | +2.4% | 15,000 |
| 2022/06/24 | 970 | 986 | 970 | 982 | +8 | +0.8% | 5,500 |
| 2022/06/23 | 956 | 980 | 956 | 974 | +4 | +0.4% | 4,200 |
| 2022/06/22 | 968 | 975 | 960 | 970 | +3 | +0.3% | 6,200 |
| 2022/06/21 | 953 | 967 | 953 | 967 | +15 | +1.6% | 4,100 |
| 2022/06/20 | 951 | 968 | 948 | 952 | +4 | +0.4% | 5,400 |
| 2022/06/17 | 939 | 957 | 939 | 948 | ±0 | ±0% | 4,500 |
| 2022/06/16 | 960 | 966 | 943 | 948 | +1 | +0.1% | 15,200 |
551～
600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,000円 | +6.8% | -13.8% | 2.67% | 9.20倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
市場注目の銘柄
チャート関連のコラム
